Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T‐cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|7|1176-1183

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.7, 2015-07, pp. : 1176-1183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Longitudinal analysis of quality‐of‐life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial

By  

CANCER, Vol. 124, Iss. 3, 2018-02 ,pp. : 571-579

John Wiley & Sons Inc

Access to resources Recommend Favorite

Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: A report from the children's oncology group

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 3, 2015-03 ,pp. : 414-418

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pre‐Morbid Developmental Vulnerabilities in Children With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 12, 2015-12 ,pp. : 2183-2188

John Wiley & Sons Inc

Access to resources Recommend Favorite

Allergic reactions and antiasparaginase antibodies in children with high‐risk acute lymphoblastic leukemia: A children's oncology group report

By  

CANCER, Vol. 121, Iss. 23, 2015-12 ,pp. : 4205-4211

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 12, 2015-12 ,pp. : 2140-2149

John Wiley & Sons Inc

Access to resources Recommend Favorite